FDA warns top marijuana company for making CBD health claims
CVS Health, which started carrying CBD skin products in some states this year, plans to remove Curaleaf products from its shelves following the FDA’s warning.
Health Care
Articles
Many companies contributed to U.S. opioid crisis, new figures show
Records kept by the federal Drug Enforcement Administration show that 76 billion oxycodone and hydrocodone pills—the vast majority of them generics, not brand names—were shipped to U.S. pharmacies from 2006 to 2012.
J&J accused of dodging liability for ‘cunning’ opioid drug push
The trial in Oklahoma City is the first of more than 1,900 local U.S. government lawsuits against drug makers and distributors over the fallout from opioid abuse.
Trump kills key drug price proposal he once embraced
The drug rebate rule would have ended a widespread practice in which drugmakers give rebates to insurance middlemen in government programs such as Medicare. The idea was to channel that money to consumers instead.
White House yanks drug ‘rebate’ plan after poor review from CBO
The nonpartisan Congressional Budget Office estimated the plan would have little impact on manufacturer prices and cost Medicare $177 billion over 10 years by leading to higher premiums subsidized by taxpayers.
Lilly losing two senior executives, including Bio-Medicines chief
Lilly shares dropped 4.6 percent in early trading after the company said Christi Shaw was leaving and Mike Harrington planned to retire.
Startup claims breakthrough in gauging pain
MindX founders think they’ve found a scientific way to measure pain and other hard-to-quantify mental health conditions, such as suicide risk, depression and post-traumatic stress disorder.
Elanco in merger talks with pharmaceutical giant Bayer, sources say
The multibillion-dollar merger would combine Elanco, the fourth-largest global player in animal health, with Bayer’s pet-health division, which ranks fifth in veterinary medicine, Reuters reported. The combination would create a dominant force in the industry.
Latest Obamacare legal battle plays out in federal appeals court
The fate of former President Barack Obama's signature health care law, and its coverage and insurance protections for millions of Americans, is again being argued in a case that appears destined for the Supreme Court.
Judge strikes down rule requiring drug ads to reveal prices
Responding to a lawsuit by Eli Lilly and two other companies, a federal judge Monday blocked a major White House initiative on prescription drug costs, saying the Trump administration lacked the legal authority to require drugmakers to disclose their prices in TV ads.
IBJ Podcast: This IU pediatrician is a health care myth buster
Should you avoid red meat? No. Should you strive for 10,000 steps a day? Not unless you just want to. So says Dr. Aaron Carroll, a pediatrician and researcher at the Indiana University School of Medicine who sees it as his life’s calling to debunk what he considers health myths and weak medical research.
IU Health executive Kitchell leaving ‘for other opportunities’
Ryan Kitchell oversees a wide variety of business operations at the state’s largest health system. His departure comes as IU Health is in the midst of numerous capital projects.
BioCrossroads chooses retired Lilly exec as new CEO
Patricia Martin, 58, former chief operating officer of Lilly’s diabetes division, will start her new job July 1, leading an organization that promotes and invests in the state’s life sciences sector.
Trump signs order that aims to reveal real health care costs
Insurers said the idea could backfire, prompting hospitals that now give deeper discounts to try to raise their own negotiated prices to match what high earners are getting. Hospitals were skeptical of the move.
Trump executive order to push for disclosure of secret health prices
The federal regulations Trump is calling for would push forward a relatively simple idea: that patients should know how much hospitals charge for common procedures.
Recovery chain with checkered history plans to open Indy treatment center
Recovery Centers of America, based in Pennsylvania, had been temporarily shut down in Massachusetts over concerns regarding patient care and safety. It is now planning to open its first Indiana treatment center.
Groups protest insulin prices outside Lilly headquarters
Several diabetes and health care advocacy groups on Thursday announced a seven-figure fundraising campaign to help fund their fight against what they consider “skyrocketing” insulin prices.
Lilly’s push into pain research starting to pay off
In recent months, the drugmaker has won federal approval to sell a drug called Emgality for two conditions: migraine pain and cluster headaches.
Health care services firm plans up to 850 jobs in Indiana
The Louisville-based company expects to invest more than $52 million to launch its Indiana operations at the River Ridge Commerce Center in Jeffersonville.
Report: Indiana opioid prescriptions down 35% since 2013
The American Medical Association Opioid Task Force 2019 Progress Report shows Indiana's reduction in opioid prescriptions from 2013 to 2018 is two percentage points higher than the national average.